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Abstract
Recently, the American Academy of Pediatrics (AAP) recommended 120/80 mm Hg as 
thresholds for identifying elevated blood pressure (BP) in adolescents aged 13-17 years. We 
aimed to compare the performance of the new definition in identifying elevated BP with 
traditional percentile-based definition. Data were obtained from the National Health and 
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Elevated BP was defined using the recommended (120/80 mm Hg) and traditional definition 
(90th percentile for sex, age and height or 120/80 mm Hg) presented in AAP guideline. The 
prevalence of elevated BP was 15.7% and 17.2% using the recommended and traditional 
definition, respectively (P<0.001). The recommended definition had high sensitivity (90.9%), 
perfect specificity (100.0%), perfect positive predictive value (100.0%) and very high 
negative predictive value (98.1%) compared with the traditional definition. The Kappa 
correlation coefficient between two definitions was 0.94 (P<0.001). Similar results can be 
observed in subgroups across sex, age and sex- and age-specific height percentile except both 
genders with young age and low height percentile. Generally, our results supported the use of 
the recommended definition for identifying elevated BP in adolescents.
Keywords: adolescent, blood pressure, identify
1. Introduction
Adult hypertension is an important public-health challenge worldwide due to its high 
prevalence and its risk for cardiovascular disease (CVD).1,2 Blood pressure (BP) levels in 
children and adolescents have been increasing alarmingly during the past decades.3,4 Elevated 
BP in children and adolescents may result in target organ damage, and increase the risks of 
adult hypertension and consequent subclinical CVD.5-8 Consequently, the early detection of 
elevated BP in children and adolescents is crucial to promote cardiovascular health and reduce 
the future CVD risk.
The US Fourth Report recommended the sex-, age-, and height-specific 90th BP 
percentiles to define pediatric elevated BP, which was accepted worldwide.9 However, the 
percentile-based definition included hundreds of abnormal BP cutoff values, which resulted in 
a complex and cumbersome decision process. Elevated BP in children and adolescents was 
frequently undiagnosed in the clinical practice.10,11 As a solution for this problem, the 
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identify elevated BP in adolescents aged 13-17 years.12 The new definition of elevated BP in 
adolescents was consistent with adult hypertension definition released recently by American 
College of Cardiology/American Heart Association.12,13 To our best knowledge, data are 
presently limited to compare the performance of the new definition in identifying elevated BP 
and concomitant cardiometabolic risks with the revised sex-, age- and height-specific 
pediatric BP standard presented in AAP guideline. The aim of this study was to evaluate this 
using the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014.
2. Methods
2.1 Study population
NHANES, which has been described in detail elsewhere, is a ongoing, nationally 
representative, and time-series cross-sectional survey to evaluate health and nutritional status 
of the resident civilian noninstitutionalized US population.14 It has been conducted by the US 
National Center for Health Statistics of the Centers for Disease Control and Prevention since 
1999 in 2-year cycle. It consists of questionnaire survey, physical examination and laboratory 
tests in each cycle. The protocols for NHANES were approved by the National Center for 
Health Statistics of the Centers for Disease Control and Prevention Institutional Review 
Board. All the participants and their guardians provided signed informed consent.
We pooled data based on NHANES 1999–2014. The present study was restricted to 9039 
individuals aged 13 to 17 years. Participants with incomplete data on age, sex, race, and 
height were excluded (n=78). Participants who did not have 3 consecutive BP values were 
also excluded (n = 1476). After these exclusions were conducted, a total of 7485 participants 
were included in the current analyses.
2.2 General examinations
In the mobile examination center, BP measurements were conducted in the sitting 
position after 5 minutes resting. BP was measured by auscultation by trained officers. The 
Korotkoff first and fifth phases were used to define systolic BP (SBP) and diastolic BP (DBP), 
respectively. Three consecutive BP readings were recorded and the mean of the last two 
readings was used in the analysis. Height was measured without shoes by trained staff using 
calibrated equipment. Weight was measured using standard and calibrated equipment. The 
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age, and race. 
2.3 Definition of elevated BP in adolescents
Childhood BP values were classified as normal BP, elevated BP, hypertension stage 1 
and stage 2 in the AAP guideline.12 In the present study, we consider children with elevated 
BP, hypertension stage 1 and stage 2 identified by the AAP guideline as having “elevated 
BP”.
2.3.1 Recommended definition 
Elevated BP in adolescents was defined as BP120/80 mm Hg.12
2.3.2 Traditional definition
Elevated BP in adolescents was defined as BP90th percentile for sex, age and height (or 
120/80 mm Hg) according to new normative pediatric BP tables issued by the AAP 
guidelines.12 The new normative pediatric BP tables were developed based on normal-weight 
children, and the details of the development process have been described elsewhere.15
2.4 Cardiometabolic risks
The cardiometabolic risks assessment included body mass index (BMI), total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol 
(LDL-C), triglyceride (TG) and glycated hemoglobin. BMI was calculated as weight divided 
by height squared (kg/m2). Laboratory data consisted of TC, HDL-C, LDL-C, TG and 
glycated hemoglobin were available for adolescents aged 13-17 years. NHANES Laboratory 
Procedures Manual released information about sample collection, preservation, measurement 
procedures and method.16
2.5 Statistical analysis
Through the use of traditional definition, BPs were classified as normal and elevated BP. 
Then, BP categories were conducted as defined in the recommended definition. We will 
report data as means (SEs) and frequencies as appropriate stratified by BP category, which 
were weighted to represent the US population.
Compared with the traditional definition, sensitivity, specificity, positive predictive value 
(PPV), and negative predictive value (NPV) were calculated to assess the performance of the 
recommended definition for identifying pediatric elevated BP. The Kappa correlation 
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Height percentiles were calculated according to the US Centers for Disease Control and 
Prevention data.17 Subgroup analyses were conducted by demographics characteristics (gender, 
age) , and sex- and age-specific height percentile.
Participants were categorized into 4 groups based on the combinations of the 
recommended and traditional definitions: participants with normal BP identified by both two 
definitions, participants with elevated BP detected by the traditional definition but normal BP 
reclassified by the recommended definition, participants with normal BP detected by the 
traditional definition but elevated BP reclassified by the recommended definition, and 
participants with elevated BP diagnosed by both two definitions. The differences were tested 
for age, sex, height, and race using the univariate linear regression models or χ2 test between 
groups. Meanwhile, multiple linear regressions after adjusted for sex, age and height were 
used to test the differences of cardiometabolic risks between groups (coded as the dummy 
variables). The analyses were adjusted for sampling weights, primary sampling units and 
strata to account for the complex survey design of NHANES 1999–2014.18 All data analyses 
were conducted with the SAS version 9.2 (SAS Institute, Cary, NC). Statistical significance 
was inferred at a 2-tailed P<0.05.
3. Results 
A total of 7485 participants were included in the present study. The prevalence of 
elevated BP was 15.7% and 17.2% using the recommended and traditional definitions, 
respectively (P<0.001). Characteristics of the participants stratified by BP category as defined 
in the recommended and traditional classifications are presented in Table S1 and S2. Table 1 
summarizes the demographic and cardiometabolic characteristics of all participants 
considering the weight for survey.
Table 2 shows the performance of the recommended definition for identifying elevated 
BP. Compared with the traditional definition, the recommended definitions had high 
sensitivity (90.9%), perfect specificity (100.0%), perfect PPV (100.0%) and very high NPV 
(98.1%). The Kappa correlation coefficient between two definitions was 0.94 (P<0.001). 
Similar results can be obtained in subgroup across sex and age. Both specificity and PPV 
were perfect (both 100%) in all subgroups across sex, age and sex- and age-specific height 
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among both sexes with young age.
Table 3 presents the comparison of demographic and cardiometabolic characteristics 
between groups classified by the combinations of 2 definitions. There are 1172, 117, 6196 and 
0 participants with elevated BP diagnosed by both two definitions, elevated BP detected by 
the traditional definition but normal BP reclassified by the recommended definition, normal 
BP identified by both two definitions, and normal BP detected by the traditional definition but 
elevated BP reclassified by the recommended definition, respectively. A total of 117 
reclassified participants were younger, shorter and had lower proportion of male than 6196 
participants who remained in the normal BP category (all Ps<0.05). Between these 2 groups, 
the cardiometabolic risk (ever BMI, TC, HDL-C, LDL-C, TG and glycated hemoglobin) was 
not significantly different with adjustment for sex, age and height (all Ps>0.05).
4. Discussion
The present study showed that recommended definition performed well in identifying 
elevated BP in adolescents aged 13-17 years, with high sensitivity, perfect specificity, perfect 
PPV and high NPV. Sensitivity differed greatly comparing data at low vs. high height 
percentile among both genders with young age. This study also demonstrated that the 
differences of cardiometabolic risks were not significant between the participants with 
elevated BP detected by the traditional definition but normal BP reclassified using the 
recommended definition and those with normal BP identified using both two definitions. 
To improve the detection of pediatric elevated BP, several simplified definitions were 
developed.19-22 Cross-sectional studies suggested that those simplified definitions had high 
sensitivities and moderate specificities in comparison with the Fourth Report.19-21 These 
results were also confirmed by a recent meta-analysis showing many simplified definitions as 
the accurate screening tools.22 Of note, several previous studies emphasized the importance of 
BP reassessment using the Fourth Report after identifying children with elevated BP by the 
simplified definition.19-22
In 2017, AAP updated the Fourth Report.12 To use friendly and align with adult 
hypertension guidelines, the most prominent change in the AAP updated guideline was the 
recommendation of absolute BP thresholds (120/80 mm Hg) on the diagnosis of elevated BP 
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replaced traditional percentile-based definition for identifying elevated BP in adolescents.12 
There were limited data regarding the difference between the recommended and traditional 
percentile-based definition revealed by AAP guidelines for adolescents. Our findings showed 
that the recommended definition had high sensitivity, perfect specificity (100%), perfect PPV 
(100%), and very high NPV compared with the traditional definition. Additionally, the 
agreement between two definitions was high.
Good performance of the recommended definition can be expected. Considering the 
characteristics of the recommended (120/80 mm Hg) and traditional definition (sex-, age-, 
and height-specific 90th BP percentiles or 120/80 mm Hg, whichever is lower), the 
reclassification of BP category can only be observed among participants whose BP 
was >corresponding sex-, age-, and height-specific 90th BP percentiles and <120/80 mm Hg. 
Consequently, only 117 (1.6%) of all participants, who were detected as elevated BP by the 
traditional definition, were reclassified as normal BP by the recommended definition. 
Meanwhile, there were 0 participants with normal BP detected by the traditional definition but 
elevated BP reclassified by the recommended definition. 
Previous simplified tools did not have perfect specificity/PPV, and very high 
sensitivity/NPV.19-22 Due to many diagnostic thresholds, these tools had the relatively low 
simplified degree.19-22 On the contrary, 120/80 threshold was simple and user-friendly. 
Clinicians can use the recommended definition to quickly identify elevated BP. Of note, 
sensitivity differed greatly comparing data at low vs. high height percentile among both 
genders with young age. The recommended definition was used with caution among younger 
(e.g. 13years) and shorter (e.g. <sex- and age-specific 25th height percentiles) participants, 
whose 90th BP percentiles for sex, age and height, as described in the AAP guidelines,12 were 
obviously lower than 120/80 mm Hg.  
Whether the participants with elevated BP as defined in the traditional definition but 
normal BP as reclassified in the recommended definition had the increased risks of CVD 
compared to those with normal BP diagnosed by both two definitions has not been clarified. 
In the current study, our findings indicated that the differences of cardiometabolic risks were 
not significant between these two groups, suggesting that participant from these two groups 















This article is protected by copyright. All rights reserved
study with 27.1-year follow-up, which demonstrated that the recommended definition (120/80 
mm Hg) performed equally with the Fourth Report in predicting adult hypertension and 
subclinical CVD.8 Similarly, previous publications summarized the convincing evidence and 
underscored the importance of conserving optimal BP (<120/80 mm Hg) in primordial 
prevention of CVD for adolescents.23
The strengths of this study included the nationally representative data from NHANES, 
the large sample size, and the high quality of data measurement (trained examiners and 
calibrated instruments), which made our results convincing and generalizable to US 
adolescents aged 13-17 years. Several limitations should be noted in the current study. First, 
NHANES was conducted in the US population, which limits the generality of our results to 
other population. Second, due to unavailable long-term follow-up data, we cannot assess 
whether adolescents whose BP was reclassified as normal BP had increased risk of CVD 
compared with those with normal BP detected by both two definitions. Further cohort studies 
are necessary to bridge this gap. Finally, the small number of participants who underwent BP 
reclassification and laboratory assessment did not allow us to perform further analysis by 
abnormal cutoffs of cardiometabolic risks. Further studies should fill in this gap.
In summary, our study suggested that the recommended definition performed well in 
identifying elevated BP in adolescents compared with the traditional standard. Our results 
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 Table 1. Characteristics of the study participants by BP category weighted for survey 
  All participants 
Normal BP   Elevated BP  
Traditional definition  Recommended definition    Traditional definition  Recommended definition  
No. of participants 7485 6196 6313  1289 1172 
Demographic characteristics       
Age (years) 15.5(0.02) 15.4(0.02) 15.4(0.02)  15.8(0.1) 15.9(0.1) 
Male (%) 49.3 46.0 45.7  66.8 70.4 
Height (cm) 166.5(0.2) 165.9(0.2) 165.8(0.2)  169.5(0.4) 170.5(0.4) 
Race       
White (%) 59.8 60.2 60.2  57.8 57.5 
Black (%) 14.3 13.5 13.5  18.5 18.9 
Mexican American (%) 12.2 12.1 12.1  12.8 13.0 
Hispanic (%) 6.5 6.7 6.7  5.4 5.3 
Other (%) 7.2 7.5 7.5  5.6 5.3 
SBP (mm Hg) 108.7(0.2) 106.0(0.1) 106.1(0.1)  122.8(0.4) 124.0(0.3) 
DBP (mm Hg) 61.1(0.3) 60.3(0.3) 60.6(0.3)  65.6(0.6) 64.5(0.6) 
Cardiometabolic characteristics       
BMI (kg/m2) 23.3(0.1) 22.9(0.1) 22.9(0.1)  25.7(0.2) 26.0(0.2) 
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HDL cholesterol (mg/dl) 50.5(0.2) 50.9(0.2) 50.9(0.2)  48.7(0.5) 48.3(0.5) 
LDL cholesterol (mg/dl) 88.4(0.6) 87.2(0.6) 87.2(0.6)  95.1(2.2) 95.7(2.4) 
Triglyceride (mg/dl) 83.1(1.3) 80.8(1.3) 80.9(1.3)  94.9(3.6) 95.9(3.9) 
Glycated hemoglobin (%) 5.2(0.01) 5.2(0.01) 5.2(0.01)  5.2(0.03) 5.2(0.02) 
BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein. 
Data are presented as means (SEs) or frequencies (%) as appropriate.  
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Table 2. Performance of the recommended definition for identifying elevated BP   
 
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Kappa coefficient* 
All  participants   90.9 100 100 98.1 0.94 
Gender 
    
Boys 95.5 100 100 98.7 0.97 
Girls 81.1 100 100 97.7 0.88 
Age 
    
13 years 79.9 100 100 97.1 0.87 
14 years 85.5 100 100 97.7 0.91 
15 years 94.8 100 100 99.0  0.97 
16 years 94.2 100 100 98.5 0.96 
17 years 94.8 100 100 98.6 0.97 
Height percentiles among boys aged 13 years  
     
＜25 40.0 100 100 92.4 0.54 
25~ 71.4 100 100 94.5 0.81 
50~ 80.0 100 100 97.2 0.88 
≥75 100 100 100 100 1 
Height percentiles among boys aged 14 years  
     
＜25 64.7 100 100 94.3 0.76 
25~ 96.8 100 100 99.3  0.98 
50~ 86.8 100 100 96.8 0.91 
≥75 97.8 100 100 99.5 0.99 
Height percentiles among boys aged 15 years  
    
＜25 95.8 100 100 99.1 0.97 
25~ 100 100 100 100 1 
50~ 100 100 100 100 1 
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Height percentiles among boys aged 16 years  
＜25 93.6 100 100 98.1 0.96 
25~ 100 100 100 100 1 
50~ 100 100 100 100 1 
≥75 100 100 100 100 1 
Height percentiles among boys aged 17 years  
＜25 95.3 100 100 98.4 0.97 
25~ 100 100 100 100 1 
50~ 100 100 100 100 1 
≥75 100 100 100 100 1 
Height percentiles among girls aged 13 years  
＜25 70.0 100 100 96.4 0.81 
25~ 72.7 100 100 97.3 0.83 
50~ 63.6 100 100 97.9 0.77 
≥75 84.6 100 100 97.3 0.90 
Height percentiles among girls aged 14 years  
＜25 50.0 100 100 96.4 0.65 
25~ 81.8 100 100 97.9 0.89 
50~ 91.7 100 100 98.9 0.95 
≥75 81.0 100 100 97.2 0.88 
Height percentiles among girls aged 15 years  
＜25 82.6 100 100 97.8 0.89 
25~ 70.0 100 100 96.6 0.81 
50~ 100 100 100 100 1 
≥75 94.4 100 100 99.2 0.97 
Height percentiles among girls aged 16 years  
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25~ 77.4 100 100 96.0 0.85 
50~ 80.0 100 100 97.8 0.88 
≥75 94.1 100 100 99.3 0.97 
Height percentiles among girls aged 17 years  
＜25 82.6 100 100 98.2 0.90 
25~ 84.2 100 100 98.1 0.91 
50~ 75.0 100 100 96.3 0.84 
≥75 93.8 100 100 99.2 0.96 
BP, blood pressure; PPV, positive predictive value; NPV, negative predictive value. 
* all Ps<0.001 
 
Table 3. Comparison of the characteristics between groups classified by the combinations of 2 definitions 
Group 1 Group 2 Group 3 
P 
  Group 1 vs 3 Group 2 vs 3 
Demographic characteristics* 
No. 1172 117 6196 
 
Age (years) 15.9(0.1) 15.0(0.2) 15.4(0.02) <0.001 0.009 
Male (%) 70.4 30.8 46.0   <0.001***   0.012*** 
Height (cm) 170.5(0.4) 159.3(0.7) 165.9(0.2) <0.001 <0.001 
Race    0.503***   0.994*** 
White (%) 57.5  60.0  60.2  
Black (%) 18.9  13.9  13.5  
Mexican American (%) 13.0  11.2  12.1  
Hispanic (%) 5.3  6.4  6.7  
Other (%) 5.3  8.5  7.5  
Cardiometabolic characteristics**    
BMI (kg/m2) 26(0.2) 23.2(0.7) 22.9(0.1) <0.001 0.293 
Total cholesterol (mg/dl) 162(1.3) 160.6(3.3) 156.1(0.5) <0.001 0.686 
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LDL cholesterol (mg/dl) 95.7(2.4) 88.3(3.9) 87.2(0.6) <0.001 0.649 
Triglyceride (mg/dl) 95.9(3.9) 85.3(11.7) 80.8(1.3) 0.001 0.648 
Glycated hemoglobin (%) 5.2(0.02) 5.5(0.2) 5.2(0.01) 0.570 0.145 
BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein. 
Data are presented as means (SEs) or frequencies (%) as appropriate. Some data were missing for cardiometabolic 
variables. 
Group 1: participants with elevated BP diagnosed by both two definitions; Group 2: participants with elevated BP 
detected by the traditional definition but normal BP reclassified by the recommended definition; Group 3: 
participants with normal BP identified by both two definitions. There are 0 participants with normal BP detected by 
the traditional definition but elevated BP reclassified by the recommended definition.                           
* Comparison of demographic characteristics between groups was performed using univariate linear regression 
models or χ2 test. 
** Comparison of cardiometabolic characteristics between groups (coded as the dummy variables) was performed 
using multiple linear regressions after adjusted for sex, age and height.  
*** Compared with adjusted alpha levels (0.05/2) due to multiple comparisons 
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